The PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel enables labs to conserve resources through the simultaneous detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV with differential diagnosis options. This multiplex assay is based on the SARS-CoV-2 assay with the lowest reported LOD as reported in the FDA Reference Panel Comparative Data. (Oct. 14, 2020). Additionally, modular and scalable extraction and liquid handling options are available to enable the processing of a broad range of samples.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.